When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AZN - AstraZeneca's Tagrisso improves survival in first-line lung cancer; shares up 2% premarket
AstraZeneca PLC
Results from the Phase 3 FLAURA study evaluating AstraZeneca's (NYSE:AZN) Tagrisso (osimertinib) in treatment-naive patients with locally advanced/metastatic EGFR mutation-positive non-small cell lung cancer (NSCLC) showed a statistically significant improvement in overall survival (OS) compared to Iressa (gefitinib) and Astellas Pharma (OTCPK:ALPMF) and Roche's (OTCQX:RHHBY) Tarceva (erlotinib), both standard-of-care treatments.
More news on: AstraZeneca PLC, Astellas Pharma Inc., Roche Holding AG, Healthcare stocks news, Stocks on the move,